1. Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma
- Author
-
Chang-Jin Kim, Chang-Seuk Lee, Moon Soo Lee, Sang Hun Lee, Hyungjoo Kim, Myoung Won Son, Tae Hyun Kim, Sang Byung Bae, Han Jo Kim, Dongjun Jeong, Moo Jun Baek, Tae Sung Ahn, and Jungkyun Im
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Lymphovascular invasion ,Colorectal cancer ,Biology ,Small hairpin RNA ,Angiopoietin-2 ,03 medical and health sciences ,0302 clinical medicine ,shRNA ,Internal medicine ,medicine ,Oncogenic function ,Oncogene ,Cancer ,Articles ,Cell cycle ,medicine.disease ,Molecular medicine ,Colorectal carcinoma ,030104 developmental biology ,Tumor progression ,030220 oncology & carcinogenesis ,Cancer research ,cardiovascular system ,hormones, hormone substitutes, and hormone antagonists - Abstract
Angiopoietin-2 (Ang-2) has been investigated in cancer primarily in terms of its angiogenic function, and its role as an oncogene has yet to be elucidated. The current study hypothesized that Ang-2 may be an oncogene and have a function in tumor progression. An investigation of the function of Ang-2 in the LoVo colorectal cancer (CRC) cell line in vitro, which expresses a high level of Ang-2, was performed by knocking down endogenous expression with a targeted short hairpin RNA. The aggressive phenotypic effects of Ang-2 on experimental and control group cells were assessed using cell proliferation, migration and invasion assays. The association between Ang-2 expression levels and clinicopathological factors was evaluated in 415 CRC tissues using immunohistochemistry. Suppressing Ang-2 expression decreased cellular proliferation, invasion and migration in an in vitro study. Ang-2 overexpression was observed in 46% of patients with CRC and was significantly associated with pT (P=0.048), pN (P
- Published
- 2017